Abstract
AbstractCompound (I), an analogue of the clinically tested calcitonin gene‐related peptide receptor antagonist MK‐3207, is identified as a CGRP receptor antagonist with suitable potency, selectivity, and pharmacokinetics to interrogate the in vivo effects of receptor blockade.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have